Asthma Global Clinical Trials Review, H1, 2016

Date: March 11, 2016
Pages: 1725
Price:
US$ 2,500.00 US$ 2,125.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A2F7004EE97EN
Leaflet:

Download PDF Leaflet

Asthma Global Clinical Trials Review, H1, 2016

SUMMARY

GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, H1, 2016' provides an overview of Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Asthma to Respiratory Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Asthma to Respiratory Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Asthma Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Asthma
Mar 03, 2016: Teva to Present New Respiratory Data on reslizumab at the 2016 Academy of Allergy, Asthma and Immunology Annual Meeting
Mar 03, 2016: Teva to Present New Respiratory Data on ProAir RespiClick (albuterol sulfate) at the 2016 Academy of Allergy, Asthma and Immunology Annual Meeting
Feb 29, 2016: Roche provides update on two identical phase III studies of lebrikizumab in people with severe asthma
Jan 08, 2016: VR315 US completes clinical study
Dec 09, 2015: Commencement of first Phase III trial of inhaled triple therapy QVM149 for asthma and milestone payment
Clinical Trial Profile Snapshots
Appendix 1722
Abbreviations 1722
Definitions 1722
Research Methodology 1723
Secondary Research 1723
About GlobalData 1724
Contact Us 1724
Disclaimer 1724
Source 1725

LIST OF TABLES

Asthma Therapeutics, Global, Clinical Trials by Region, 2016
Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016
Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016
Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016
Asthma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016
Asthma Therapeutics Clinical Trials, North America, Top Countries, 2016
Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016
Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016
Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2016
Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016
Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016
Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2016
Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016
Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016
Asthma Therapeutics, Global, Clinical Trials by Phase, 2016
Asthma Therapeutics, Global, Clinical Trials In Progress by Phase 2016
Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2016
Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2016
Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016
Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2016
Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016
Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016

LIST OF FIGURES

Asthma Therapeutics, Global, Clinical Trials by Region (%), 2016
Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016
Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016
Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016
Asthma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016
Asthma Therapeutics Clinical Trials, North America, Top Countries (%), 2016
Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016
Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016
Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2016
Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016
Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016
Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2016
Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016
Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016
Asthma Therapeutics, Global, Clinical Trials by Phase (%), 2016
Asthma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016
Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2016
Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2016
Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016
Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2016
Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016
Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016
GlobalData Methodology 1723

COMPANIES MENTIONED

AstraZeneca Plc
GlaxoSmithKline Plc
Novartis AG
Merck & Co., Inc.
C. H. Boehringer Sohn AG & Co. KG
Teva Pharmaceutical Industries Limited
F. Hoffmann-La Roche Ltd.
Chiesi Farmaceutici SpA
Pfizer Inc.
Takeda Pharmaceutical Company Limited
Skip to top


Ask Your Question

Asthma Global Clinical Trials Review, H1, 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: